Stay updated on Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed descriptions regarding the study of NRP104, its potential abuse, and the inclusion criteria for participants. Additionally, the revision number has been updated.SummaryDifference42%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.